Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
life sciences
national blog main
5
×
biotech
clinical trials
startups
boston blog main
eli lilly
indiana blog main
medical device
new york blog main
san francisco blog main
type 1 diabetes
american diabetes association
beta bionics
boston top stories
deals
diabetes
diabetes type 2
indiana top stories
investing
new york top stories
raleigh-durham blog main
san diego blog main
san francisco top stories
seattle blog main
software
texas blog main
texas top stories
510k
adaptive biotechnologies
alector
allergan
ame cloud ventures
american journal of medicine
amgen
amputation
amputee
apollomics
arrowmark partners
What
diabetes
5
×
blood
eli
levels
medical
patients
sugar
advocates
aim
antonio
appetite
approval
available
balance
beta
bid
bio
biome
bionics
black
boehringer
bread
butter
buyout
cancer
cash
closed
developing
device
diamond’s
driven
drug
drugs
expand
eyes
fallen
fda
food
foot
giant
Language
unset
Current search:
diabetes
×
fda
×
" national blog main "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
5 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
MR3 Health Takes Aim at Foot Ulcers as San Antonio Tackles Diabetes